Cargando…

Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease

The aim of this study was to explore concentrations differences of soluble amyloid precursor protein (sAPP) α and β in blood plasma in patients with probable Alzheimer's disease (AD) and cognitively healthy age-matched control subjects, as well as patients with behavioural variant frontotempora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perneczky, R, Guo, L-H, Kagerbauer, S M, Werle, L, Kurz, A, Martin, J, Alexopoulos, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591004/ https://www.ncbi.nlm.nih.gov/pubmed/23423136 http://dx.doi.org/10.1038/tp.2013.11

Ejemplares similares

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
por: Alexopoulos, Panagiotis, et al.
Publicado: (2016)

Amyloid Precursor Protein and Alzheimer’s Disease
por: Orobets, Kseniia S., et al.
Publicado: (2023)

Heterogeneous Association of Alzheimer’s Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses
por: Willén, Katarina, et al.
Publicado: (2017)

Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
por: Trysberg, Estelle, et al.
Publicado: (2004)

Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
por: Grimmer, Timo, et al.
Publicado: (2012)

LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo
por: Grimmer, Timo, et al.
Publicado: (2014)

Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
por: Ehehalt, Robert, et al.
Publicado: (2003)

Selectivity to amyloid-β precursor protein cleavage provides hope against Alzheimer's
por: Tomita, Taisuke, et al.
Publicado: (2011)

Altered β-Amyloid Precursor Protein Isoforms in Mexican Alzheimer’s Disease Patients
por: Sánchez-González, V. J., et al.
Publicado: (2006)

Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease
por: Dawkins, Edgar, et al.
Publicado: (2014)

Effect of soluble amyloid precursor protein-alpha on adult hippocampal neurogenesis in a mouse model of Alzheimer’s disease
por: Ohline, Shane M., et al.
Publicado: (2022)

Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer’s Disease
por: Bi, Christopher, et al.
Publicado: (2019)

Soluble amyloid-β precursor peptide does not regulate GABA(B) receptor activity
por: Rem, Pascal Dominic, et al.
Publicado: (2023)

Copper binding to the Alzheimer’s disease amyloid precursor protein
por: Kong, Geoffrey K.-W., et al.
Publicado: (2007)

Amyloid precursor protein and amyloid precursor-like protein 2 in cancer
por: Pandey, Poomy, et al.
Publicado: (2016)

Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
por: Pfundstein, Grant, et al.
Publicado: (2022)

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
por: García-Ayllón, María-Salud, et al.
Publicado: (2017)

Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
por: Zhang, She-Qing, et al.
Publicado: (2013)

Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's β-secretase
por: Scholefield, Zoe, et al.
Publicado: (2003)

Soluble β-amyloid Precursor Protein Alpha Binds to p75 Neurotrophin Receptor to Promote Neurite Outgrowth
por: Hasebe, Noriko, et al.
Publicado: (2013)

Blood‐brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein‐β in patients with subcortical small‐vessel disease
por: Kettunen, Petronella, et al.
Publicado: (2022)

Diurnal Patterns of Soluble Amyloid Precursor Protein Metabolites in the Human Central Nervous System
por: Dobrowolska, Justyna A., et al.
Publicado: (2014)

Endothelial expression of human amyloid precursor protein leads to amyloid β in the blood and induces cerebral amyloid angiopathy in knock-in mice
por: Tachida, Yuriko, et al.
Publicado: (2022)

Gamma frequency light flicker regulates amyloid precursor protein trafficking for reducing β‐amyloid load in Alzheimer's disease model
por: Shen, Qi, et al.
Publicado: (2022)

Amyloid precursor protein modulates β-catenin degradation
por: Chen, Yuzhi, et al.
Publicado: (2007)

β-Amyloid precursor protein (APP) and the human diseases
por: Nguyen, Khue Vu
Publicado: (2019)

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
por: Wang, Min Jeong, et al.
Publicado: (2017)

Soluble Amyloid Precursor Protein Induces Rapid Neural Differentiation of Human Embryonic Stem Cells
por: Freude, Kristine K., et al.
Publicado: (2011)

Justicidin A Reduces β-Amyloid via Inhibiting Endocytosis of β-Amyloid Precursor Protein
por: Chun, Yoon Sun, et al.
Publicado: (2019)

Mutations in the β-amyloid precursor protein in familial Alzheimer’s disease increase Aβ oligomer production in cellular models
por: Ohshima, Yoichi, et al.
Publicado: (2018)

Amyloid blood biomarker detects Alzheimer's disease
por: Nabers, Andreas, et al.
Publicado: (2018)

Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease
por: Basi, Guriqbal S, et al.
Publicado: (2010)

Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants
por: Gorman, Paul M, et al.
Publicado: (2008)

The amyloid precursor protein: beyond amyloid
por: Zheng, Hui, et al.
Publicado: (2006)

Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β production
por: Khan, Ayesha, et al.
Publicado: (2023)

Familial Alzheimer’s disease mutations in amyloid protein precursor alter proteolysis by γ-secretase to increase amyloid β-peptides of ≥45 residues
por: Devkota, Sujan, et al.
Publicado: (2021)

Targeting apolipoprotein E and N-terminal amyloid β-protein precursor interaction improves cognition and reduces amyloid pathology in Alzheimer’s mice
por: Sawmiller, Darrell, et al.
Publicado: (2023)

Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer’s disease
por: Boix, Claudia P., et al.
Publicado: (2020)

TDP-43 and amyloid precursor protein processing: implications for Alzheimer’s disease
por: Hicks, David A.
Publicado: (2020)

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
por: Steinacker, Petra, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qg571srb12cl7lbvqedbmk4a3m